Catalyst Wire Dossier Catalyst Wire Dossier

Pentavalent DTwP-Hib-HepB vaccine

diphtheria-tetanus-pertussis-hepatitis B-haemophilus influenzae type b vaccine · Novartis Vaccines
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pentavalent DTwP-Hib-HepB vaccine, covering 2017-05-19 to 2017-05-19. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity, Safety and Tolerability of a Fully Liquid Pentavalent (DTwP-Hib-Hep B) Vaccine in Infants 6-8 Weeks of Age [Phase 3]

See pricing